osimertinib for Lung Cancer: 29 Real Stories
29 stories match lung cancer and osimertinib. 11 of them mention surgery.
EGFR Lung Cancer Patient Story
This Noxte entry followed a disappointing oncology update on 19 April. The patient learned that the blood sample sent to the laboratory was negative for T790M resistance, so he could not enter the AZD9291/osimertinib clinical trial. He found that frustrating…
Read this storyLung Cancer Patient Story
This Noxte post explained how liquid biopsy was beginning to affect the patient’s lung cancer care. He had been participating in blood-based monitoring to track treatment effects and possible resistance. At an oncology visit, his doctors had the latest blood…
Read this storyLung Cancer Patient Story
By January 2016, this Spanish lung cancer blogger was marking 2 years of survival while facing a new treatment setback. Recent bronchoscopy and blood testing confirmed that the cancer had developed resistance, including the T790M mutation. That finding…
Read this storyLung Cancer Patient Story
In January 2016, this lung cancer patient learned that a recent CT scan explained his worsening cough. The scan showed clear progression: the right upper-lobe mass had grown to about 4.9 x 5 cm, with extension to the visceral pleura, involvement around the…
Read this storyEGFR Non-Small Cell Lung Cancer Patient Story
In December 2015, this patient was living with EGFR-mutated non-small cell lung cancer and taking Tarceva, also called erlotinib, which he had started in January. Much of this post reflected his effort to understand the fast-changing treatment landscape. He…
Read this story